Literature DB >> 34129853

New bioactive peptides from the venom gland of a social hornet Vespa velutina.

Yi-Chuan Meng1, Xiang-Gui Mo1, Tian-Tian He2, Xin-Xin Wen1, James-C Nieh3, Xin-Wang Yang4, Ken Tan5.   

Abstract

Bacterial resistance to drugs is a global problem requiring the urgent development of new antibiotics. Antimicrobial peptides (AMPs) are excellent candidates for the design of novel antibiotics to combat microbial resistance. In this research, we identified four new peptides (U-VVTX-Vp1a, U-VVTX-Vp1b, U-VVTX-Vp2a, and U-VVTX-Vp2b, respectively) from the venom of Vespa velutina, and tested their antimicrobial, antioxidant, and hemolytic effects. All four peptides showed scavenging ability against DPPH, ABTS+, and •OH free radicals. Of note, Vp1b strongly inhibited the growth of Staphylococcus aureus and Escherichia coli bacteria at concentrations of 60 and 120 μM. Due to their low hemolytic activity, all four peptides could be utilized in the development of new antioxidants and as candidates for the design of novel antimicrobial agents.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial peptides; Antioxidative peptides; Venom gland; Vespa velutina

Year:  2021        PMID: 34129853     DOI: 10.1016/j.toxicon.2021.06.002

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  2 in total

1.  Amphibian-derived peptide homodimer OA-GL17d promotes skin wound regeneration through the miR-663a/TGF-β1/Smad axis.

Authors:  Yue Zhang; Ying Wang; Lin Zeng; Yixiang Liu; Huiling Sun; Shanshan Li; Siyu Wang; Longjun Shu; Naixin Liu; Saige Yin; Junsong Wang; Dan Ni; Yutong Wu; Ying Yang; Li He; Buliang Meng; Xinwang Yang
Journal:  Burns Trauma       Date:  2022-07-12

2.  Characterization of the Composition and Biological Activity of the Venom from Vespa bicolor Fabricius, a Wasp from South China.

Authors:  Yong-Hua Wu; Yu Zhang; Dan-Qiao Fang; Jing Chen; Jing-An Wang; Lin Jiang; Zhu-Fen Lv
Journal:  Toxins (Basel)       Date:  2022-01-14       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.